Pretty much. Idronoxil the active ingredient in Veyond was discovered way back in 1990s it 20 year patent expired in 2017 I believe. Its proven safety back then was well and truly .established. Nox66 the new delivery was invented back in 2012. Again its safety has been established in quite a few phase I trials already. Thus another IND though a milestone is not all that a big deal with this drug's history. A phase one trial is just that......YAWN!!!!!!
Ann: Veyonda FDA Approved Trial to Commence, page-12
-
- There are more pages in this discussion • 21 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
11.0¢ |
Change
0.005(4.76%) |
Mkt cap ! $32.14M | |||
| Open | High | Low | Value | Volume |
| 11.0¢ | 11.0¢ | 11.0¢ | $1.03K | 9.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 55467 | 11.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 11.5¢ | 50153 | 2 |
View Market Depth
| Last trade - 15.35pm 07/10/2024 (20 minute delay) ? |
| NOX (ASX) Chart |